INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in aTyr Pharma, Inc. of Class Action Lawsuit and Upcoming Deadlines – ATYR GlobeNewswire October 24, 2025 NEW YORK, Oct. 24, 2025 (GLOBE NEWSWIRE) — Pomerantz LLP announces that a class action lawsuit has been filed against aTyr Pharma, Inc. (“aTyr” or the […]

INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in Cytokinetics, Incorporate of Class Action Lawsuit and Upcoming Deadlines – CYTK GlobeNewswire October 24, 2025 NEW YORK, Oct. 24, 2025 (GLOBE NEWSWIRE) — Pomerantz LLP announces that a class action lawsuit has been filed against Cytokinetics, Incorporate (“Cytokinetics” or the “Company”) (NASDAQ:

Remix Therapeutics Announces Positive Preliminary Data from Phase 1 Study of REM-422 in Patients with Adenoid Cystic Carcinoma at the 2025 AACR-NCI-EORTC International Conference on Molecular Targets and Cancer Therapeutics GlobeNewswire October 24, 2025 Preliminary Results Yield 43% Overall Response Rates (via RECIST) in the Efficacy Population Data Demonstrate REM-422, the First-in-Class Small Molecule MYB

INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Arcturus Therapeutics Holdings Inc. – ARCT GlobeNewswire October 24, 2025 NEW YORK, Oct. 24, 2025 (GLOBE NEWSWIRE) — Pomerantz LLP is investigating claims on behalf of investors of Arcturus Therapeutics Holdings Inc. (“Arcturus” or the “Company”) (NASDAQ: ARCT). Such investors are advised to

INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in Lantheus Holdings, Inc. of Class Action Lawsuit and Upcoming Deadlines – LNTH GlobeNewswire October 24, 2025 NEW YORK, Oct. 24, 2025 (GLOBE NEWSWIRE) — Pomerantz LLP announces that a class action lawsuit has been filed against Lantheus Holdings, Inc. (“Lantheus” or the

North Dallas Bank & Trust Co. Announces Third Quarter Earnings GlobeNewswire October 24, 2025 DALLAS, Oct. 24, 2025 (GLOBE NEWSWIRE) — NDBT (North Dallas Bank & Trust Co.), an independent community bank established in 1961, today announced net earnings for three months of $2,153,174 or $0.84 per share, and net earnings for nine months of

Next-Gen Proteomics Market Size, Trends, Competitive Analysis – Towards Healthcare This report provides a comprehensive analysis of the next-generation proteomics market, highlighting key trends, drivers and growth opportunities shaping the industry. It is prepared by Towards Healthcare, a sister firm of Precedence Research, known for delivering in-depth healthcare market insights. GlobeNewswire October 24, 2025 Ottawa,

Filtration in Biologics Market: Trends, Growth Drivers and Opportunities (2024-2034) This report by Towards Healthcare, a sister firm of Precedence Research, provides an in-depth analysis of the filtration in biologics market. It highlights key trends, growth drivers, and emerging opportunities shaping the industry from 2024 to 2034. GlobeNewswire October 24, 2025 Ottawa, Oct. 24, 2025

Pomerantz Law Firm Announces the Filing of a Class Action Against Dow Inc. and Certain Officers – DOW GlobeNewswire October 24, 2025 NEW YORK, Oct. 24, 2025 (GLOBE NEWSWIRE) — Pomerantz LLP announces that a class action lawsuit has been filed against Dow Inc. (“Dow” or the “Company”) (NYSE: DOW) and certain officers. The class

INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in Quanex Building Products Corporation of Class Action Lawsuit and Upcoming Deadlines – NX GlobeNewswire October 24, 2025 NEW YORK, Oct. 24, 2025 (GLOBE NEWSWIRE) — Pomerantz LLP announces that a class action lawsuit has been filed against Quanex Building Products Corporation (“Quanex”